Literature DB >> 31955495

Left ventricular hypertrophy in isolated and dual masked hypertension.

Cesare Cuspidi1,2, Rita Facchetti1, Fosca Quarti-Trevano1, Raffaella Dell'Oro1, Marijana Tadic3, Guido Grassi1, Giuseppe Mancia1.   

Abstract

Masked hypertension (MH) is defined as normal office blood pressure (BP) and elevated ambulatory BP (ABP) or home BP or both. This study assessed the association of MH (ie, isolated home, isolated ABP and dual MH) with echocardiographic left ventricular hypertrophy (LVH). The present analysis of the PAMELA study included 1087 untreated and treated participants with normal office BP and a measurable LV mass (LVM). A total of 193 individuals (17.7%) had any MH (ie, normal office BP, elevated ABP or home BP or both), 48 had dual MH (25%), 62 isolated ambulatory MH (32%), and 83 isolated home MH (43%). Average LVM indexed to body surface area was superimposable in the three MH phenotypes (being the largest difference between groups <3 g/m2 ) and significantly higher than in true normotensives. This was also for the LVH prevalence that varied across the MH subgroups in a narrow range (from 8.3% to 10.8%). In conclusion, individuals from the general population with isolated MH, in which either home or ABP was elevated, exhibited an increased risk of LVH similar to that entailed by dual MH. Our findings add the notion both home and ABP measurements are useful to more accurately assess the risk of LVH associated with MH in the community.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  general population; left ventricular hypertrophy; masked hypertension

Mesh:

Year:  2020        PMID: 31955495      PMCID: PMC8029877          DOI: 10.1111/jch.13808

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  17 in total

1.  Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage.

Authors:  Valérie Gaborieau; Nicolas Delarche; Philippe Gosse
Journal:  J Hypertens       Date:  2008-10       Impact factor: 4.844

2.  Ambulatory blood pressure normality: results from the PAMELA study.

Authors:  G Mancia; R Sega; C Bravi; G De Vito; F Valagussa; G Cesana; A Zanchetti
Journal:  J Hypertens       Date:  1995-12       Impact factor: 4.844

3.  Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon?

Authors:  George S Stergiou; Eleanna V Salgami; Dimitris G Tzamouranis; Leonidas G Roussias
Journal:  Am J Hypertens       Date:  2005-06       Impact factor: 2.689

4.  Untreated Masked Hypertension and Subclinical Cardiac Damage: A Systematic Review and Meta-analysis.

Authors:  Cesare Cuspidi; Carla Sala; Marijana Tadic; Marta Rescaldani; Guido Grassi; Giuseppe Mancia
Journal:  Am J Hypertens       Date:  2014-12-01       Impact factor: 2.689

5.  Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study.

Authors:  Cesare Cuspidi; Rita Facchetti; Carla Sala; Michele Bombelli; Francesca Negri; Stefano Carugo; Roberto Sega; Guido Grassi; Giuseppe Mancia
Journal:  J Hypertens       Date:  2012-05       Impact factor: 4.844

6.  Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation.

Authors:  G Mancia; A Zanchetti; E Agabiti-Rosei; G Benemio; R De Cesaris; R Fogari; A Pessina; C Porcellati; A Rappelli; A Salvetti; B Trimarco; E Agebiti-Rosei; A Pessino
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

7.  Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements.

Authors:  Giuseppe Mancia; Michele Bombelli; Gianmaria Brambilla; Rita Facchetti; Roberto Sega; Elena Toso; Guido Grassi
Journal:  Hypertension       Date:  2013-05-28       Impact factor: 10.190

8.  Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.

Authors:  George S Stergiou; Kei Asayama; Lutgarde Thijs; Anastasios Kollias; Teemu J Niiranen; Atsushi Hozawa; José Boggia; Jouni K Johansson; Takayoshi Ohkubo; Ichiro Tsuji; Antti M Jula; Yutaka Imai; Jan A Staessen
Journal:  Hypertension       Date:  2014-01-13       Impact factor: 10.190

9.  Phenotypes of masked hypertension: Isolated ambulatory, isolated home and dual masked hypertension.

Authors:  George S Stergiou; Konstantinos G Kyriakoulis; Richard J McManus; Emmanuel A Andreadis; Antti Jula; Anastasios Kollias; Annika Lindroos; Angeliki Ntineri; Claire Schwartz; Teemu J Niiranen
Journal:  J Hypertens       Date:  2020-02       Impact factor: 4.844

10.  Left ventricular hypertrophy in isolated and dual masked hypertension.

Authors:  Cesare Cuspidi; Rita Facchetti; Fosca Quarti-Trevano; Raffaella Dell'Oro; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

View more
  2 in total

1.  Left ventricular hypertrophy in isolated and dual masked hypertension.

Authors:  Cesare Cuspidi; Rita Facchetti; Fosca Quarti-Trevano; Raffaella Dell'Oro; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

2.  Disruption of STAT6 Signal Promotes Cardiac Fibrosis Through the Mobilization and Transformation of CD11b+ Immature Myeloid Cells.

Authors:  Weiwei Zhang; Baoling Zhu; Suling Ding; Xiangfei Wang; Jian Wu; Xiaowei Zhu; Yunzeng Zou; Junbo Ge; Minghong Tong; Xiangdong Yang
Journal:  Front Physiol       Date:  2020-10-22       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.